A string of facility closures and workforce cuts threatens the Seattle suburb’s ambitions to become a major biotech center The signs of distress...
ByThe RegistryAugust 28, 2025Biotech company writes down facilities amid shift to outsourced production and mounting losses Sana Biotechnology recorded a $44.6 million impairment charge in the...
ByThe RegistryAugust 12, 2025Seattle’s life sciences sector continues to expand, driven by strong venture capital investment, strategic acquisitions and steady employment growth, according to a recently...
ByThe RegistryMarch 31, 2025Gilead Sciences Inc., the global biopharmaceutical company renowned for its HIV treatments, is set to close its Seattle office. As outlined in a...
ByThe RegistryNovember 14, 2024BioMed Realty, a Blackstone portfolio company specializing in real estate solutions for the life science and technology sectors, has announced today the signing...
ByThe RegistryAugust 14, 2024By The Registry Staff Seattle-based Sana Biotechnology Inc. officially opened its new 80,000-square-foot manufacturing facility in Bothell on Friday. The facility, located in...
ByThe RegistryAugust 7, 2024By The Registry Staff Sana Biotechnology Inc., a Seattle-based life science company, has taken a step toward realizing its goal of developing a...
ByThe RegistryAugust 1, 2023Replacement of Fremont, CA Facility Estimated to Save Over $100M in the Next Three Years Global Cell Therapy Manufacturing Expert Snehal Patel Appointed...
ByThe RegistryJune 1, 2022By Meghan Hall Pasadena, Calif.-based Alexandria Real Estate Equities has been a prolific developer in the region, developing key properties into life science-...
ByThe RegistryJuly 16, 2019 
Signup for news and special announcements!
You have successfully joined our subscriber list.